Nigel Brown has more than 25 years of experience in leadership and strategy in the pharmaceutical, biotechnology and contract research industries. Dr. Brown founded and serves as the Chief Executive Officer of Princeton Healthcare Advisory, LLC, an advisory firm specializing in support for growth-focused investors in healthcare and life science sectors. Dr. Brown is an Advisor for Rothschild & Co., Five Arrows Managers LLP and previously served as General Partner for Trevi Health Capital, a healthcare focused specialty investment firm, and held oversight and advisory roles for various organizations. He was Corporate Vice President of Covance, Inc. where he executed numerous transactions including the strategic sale of Covance to LabCorp (NYSE: LH) in 2014. Dr. Brown has extensive experience in acquisitions and strategic partnerships in the biomedical and technology sectors and is a skilled partner in facilitating investments and corporate transactions.

Trained as an analytical chemist, Dr. Brown has also worked for several major pharmaceutical companies. Dr. Brown received his BA in Chemistry and PhD in Physiological Sciences from the University of Oxford, his MBA from The Open University and held the Nestlé post-doctoral fellowship at the Massachusetts Institute of Technology. Dr. Brown also serves on the board for Inotiv, Inc. (NASDAQ: NOTV).